微小RNA(miRNA)是一类天然存在的小型(约22个核苷酸长)非编码RNA,可调节转录后基因表达以控制细胞过程、发育、细胞分化和体内平衡。微小RNA对于胚胎、细胞和组织发育至关重要,可调节细胞分化、增殖和凋亡,因此在人类生殖中具有重要意义。同时,miRNA的异常表达或功能被发现与包括癌症在内的各种人类疾病的发生或发展密切相关。鉴于其在生理学和病理学中的重要作用,miRNA正在成为化学生物学研究(包括调节和检测)的新型生物分子靶点。
miRNA的生成涉及多个步骤。大多数 miRNA 都是通过经典生物合成途径产生的,该途径包括 RNA 聚合酶 II 转录以产生初级转录本 (pri-miRNA),以及微处理器复合物裂解以在细胞核中产生发夹结构前体 miRNA (pre-miRNA)。然后,pre-miRNA 被输出到细胞质中,在那里被 Dicer 酶裂解形成双链 RNA 双链。只有双链 RNA 双链中的一条单链形成成熟的 miRNA,并被整合到 RNA 诱导沉默复合物 (RISC) 中,该复合物引导 RISC 中的 Argonaute (AGO) 蛋白与 3' 非翻译区 (UTR) 结合,以抑制蛋白质翻译或促进 mRNA 降解。除了经典 miRNA 生物合成途径外,还存在非经典微处理器独立或 Dicer 独立的 miRNA 生物合成途径。尽管 miRNA 主要参与基因表达的下调,但也有 miRNA 促进基因表达的报道。此外,在特定细胞类型中,miRNA 与其靶标之间的关系并不总是一对一的。事实上,单个 miRNA 可能调节许多 mRNA 靶标,反之,单个 mRNA 靶标也可以受许多 miRNA 调节。
MicroRNAs (miRNAs) are a naturally occurring class of small (approximately 22 nucleotides long) non-coding RNAs that regulate post-transcriptional gene expression to control cellular processes, development, cell differentiation, and homeostasis. MicroRNAs are essential for embryo, cell, and tissue development, regulating cell differentiation, proliferation, and apoptosis, hence their importance in human reproduction. Meanwhile, abnormal expression or function of miRNAs are found to be closely associated with the occurrence or development of various human diseases, including cancers. In light of their significant roles in physiology and pathology, miRNAs are emerging as novel biomolecular targets for chemical-biological studies, including regulation and detection.
Multiple steps are involved in the generation of miRNAs. Most miRNAs are produced by the canonical biogenesis pathway, which involves transcription by RNA polymerase II to make a primary transcript (pri-miRNA) and cleavage by the microprocessor complex to yield a hairpin precursor miRNA (pre-miRNA) in the nucleus. The pre-miRNA is then exported into the cytoplasm, where cleavage by the enzyme Dicer creates a double-stranded RNA duplex. Only a single strand from the double-stranded RNA duplex forms the mature miRNA and is incorporated into the RNA-induced silencing complex (RISC), which guides the binding of Argonaute (AGO) proteins in the RISC to the 3’untranslated region (UTR) to either repress protein translation or promote mRNA degradation. In addition to canonical miRNA biogenesis pathways, non-canonical microprocessor-independent or Dicer-independent miRNA biogenesis pathways also exist. Despite miRNAs being mostly involved in the down-regulation of gene expression, there are reports of miRNAs promoting gene expression. In addition, relationships between miRNAs and their targets are not always one-to-one in a specific cell type. In fact, a single miRNA may regulate many mRNA targets, and conversely, a single mRNA target also can be regulated by many miRNAs.
Benzazepinoquinoline-spermine(Compound PA-3)是一种高效的前 miR-372 络合剂,能特异性抑制其由 Dicer 介导的加工过程(IC₅₀ = 0.58 μM),与 pre-miR-372 具有强亲和力(KD = 0.11 μM),对 pre-miR-373 也表现出高活性(IC₅₀ = 0.29 μM),但对 pre-miR-17、pre-miR-21 和 pre-miR-155 的抑制活性显著降低(IC₅₀ 分别为 0.84 μM、1.43 μM 和 1.07 μM),可用于癌症研究。
Cl-amidine 是一种口服有效的 PAD 抑制剂,对 PAD1、PAD3 和 PAD4 的 IC50 值分别为 0.8 μM、6.2 μM 和 5.9 μM,可诱导癌细胞凋亡;Cl-amidine TFA 可诱导 miR-16(miRNA-16、microRNA-16)并引起细胞周期阻滞,而 Cl-Amidine 可阻断组蛋白3瓜氨酸化和中性粒细胞胞外陷阱的形成,并提高败血症小鼠的存活率。
口服有效的 PAD 抑制剂 Cl-amidine hydrochloride 对 PAD1、PAD3 和 PAD4 的 IC50 值分别为 0.8 μM、6.2 μM 和 5.9 μM,可诱导癌细胞凋亡及 miR-16(miRNA-16、microRNA-16)从而引起细胞周期阻滞,并可阻断组蛋白 3 瓜氨酸化和中性粒细胞胞外陷阱的形成,提高败血症小鼠的存活率。
Cl-amidine TFA 是一种口服有效的 PAD 抑制剂,对 PAD1、PAD3 和 PAD4 的 IC50 值分别为 0.8 μM、6.2 μM 和 5.9 μM,可诱导癌细胞凋亡及 miR-16(miRNA-16、microRNA-16)表达进而引起细胞周期阻滞,并能阻断组蛋白 3 瓜氨酸化和中性粒细胞胞外陷阱的形成,提高败血症小鼠的存活率。
Cobomarsen (MRG-106) 是一种靶向 miR-155 的寡核苷酸抑制剂,可抑制与细胞存活相关的多条基因通路(JAK/STAT、MAPK/ERK 和 PI3K/AKT),并可用于 B 细胞淋巴瘤的研究。
Cobomarsen sodium 是一种 miR-155 寡核苷酸抑制剂,通过抑制与细胞存活相关的 JAK/STAT、MAPK/ERK 和 PI3K/AKT 等多种基因通路,可用于 B 细胞淋巴瘤的研究。
Cy3 MicroRNA Antagomir Negative Control 是一种 Cy3 标记的 MicroRNA Antagomir Negative Control (MS-W34175),其序列基于 cel-mir-239b 设计,被广泛用作阴性对照,并且与人类、小鼠和大鼠的 miRNA 具有最小的序列一致性。
Cy5-MicroRNA Mimic Negative Control 是 Cy5 标记的 MicroRNA Mimic Negative Control (MS-S47510),后者是一种 21 个核苷酸的 miRNA 模拟物,可作为阴性对照使用,其序列根据被广泛用作阴性对照的 cel-mir-239b 序列设计,与人类、小鼠和大鼠的 miRNA 具有最小的序列一致性。